The DOI matches its Crossref record.
Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome
Abstract
There is a pressing need for the development of visual aids that will facilitate the detection of oral premalignant lesions (OPLs) with a high-risk of progression. Preliminary data suggest that toluidine blue stain may be preferentially retained by OPLs with high-risk molecular clones. In this study, we monitored OPLs from 100 patients without any history of oral cancer for an average of 44 months in order to evaluate the association of toluidine blue status with clinicopathologic risk factors, molecular patterns (microsatellite analysis on seven chromosome arms: 3p, 9p, 4q, 8p, 11q, 13q, and 17p) and outcome. Toluidine blue–positive staining correlated with clinicopathologic risk factors and high-risk molecular risk patterns. Significantly, a >6-fold elevation in cancer risk was observed for toluidine blue–positive lesions, with positive retention of the dye present in 12 of the 15 lesions that later progressed to cancer (P = 0.0008). This association of toluidine blue status with risk factors and outcome was evident even when the analysis was restricted to OPLs with low-grade or no dysplasia. Our results suggest the potential use of toluidine blue in identifying high-risk OPLs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Critical evaluation of diagnostic aids for the detection of oral cancer
Lingen, M. W., Kalmar, J. R., Karrison, T., & Speight, P. M. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.011 · Cited by 718
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
Pai, S. I., & Westra, W. H. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092158 · Cited by 508
Screening programmes for the early detection and prevention of oral cancer
Brocklehurst, P., Kujan, O., O'Malley, L., Ogden, G. R., Shepherd, S., & Glenny, A.-M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004150.pub4 · Cited by 459
Molecular biology of squamous cell carcinoma of the head and neck
Perez-Ordoñez, B., Beauchemin, M., & Jordan, R. C. K. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.007641 · Cited by 314
Adjunctive Techniques for Oral Cancer Examination and Lesion Diagnosis
Patton, L. L., Epstein, J. B., & Kerr, A. R. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0276 · Cited by 310
Self-citation
Metadata
- Authors
- Zhang, L., Williams, M., Poh, C. F., Laronde, D., Epstein, J. B., Durham, S., Nakamura, H., Berean, K., Hovan, A., Le, N. D., Hislop, G., Priddy, R., Hay, J., Lam, W. L., & Rosin, M. P.
- Venue
- Cancer Research
- Published
- 2005-09-01
- Volume
- 65
- Issue
- 17
- Pages
- 8017-8021
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2117635193
- Cited by
- 176
- References
- 0
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3153
- The paper
- Zhang, L., Williams, M., Poh, C. F., Laronde, D., Epstein, J. B., Durham, S., Nakamura, H., Berean, K., Hovan, A., Le, N. D., Hislop, G., Priddy, R., Hay, J., Lam, W. L., & Rosin, M. P. (2005). Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.